RT Journal Article
SR Electronic
T1 Cardiopulmonary imaging utilization and findings among hospitalized COVID-19 patients in Latin America (From RIMAC: Registry IMAging Cardiopulmonary among hospitalized COVID-19 patients in LATAM)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.10.22269002
DO 10.1101/2022.01.10.22269002
A1 Spina, Salvador V
A1 Vieira, Marcelo L Campos
A1 Herrera, César J.
A1 Múnera Echeverri, Ana G.
A1 Rojo, Pamela
A1 Arrioja Salazar, Alma S
A1 Vázquez Ortiz, Zuilma Y
A1 Arellano, Roberto Baltodano
A1 Reyes, Graciela
A1 Millán, Rocío Aceves
A1 Calderón González, Juan A
A1 Camarozano, Ana C
A1 Avilés, Edgar
A1 Cabrera, Marco A
A1 Grande Ratti, María F
A1 Lowenstein, Jorge
A1 Vyhmeister, Rodrigo Hernández
A1 Santana, Pamela Piña
A1 Ibarra Burgos, Jaime A.
A1 Rivera, Alejandra
A1 Fernández Campos, Beatriz A
A1 Cupe Chacalcaje, Kelly M
A1 De Santos, Mariela
A1 Afonso, Tania R
A1 Aquino, Tomás Miranda
A1 Lalyre Acosta, Ana L
A1 Domínguez, Beatriz
A1 Campos, Federico
A1 Alday Ramirez, Sergio M
A1 Cachicatari Beltran, Angela V
A1 Alvarez, Daniela
A1 de Oliveira Roveri, Patricia
A1 Ixcamparij, Carlos Rosales
A1 López, Ender
A1 Vargas, Pedro
A1 Flamand, Maximiliano Flores
A1 López Martínez, Rosa L
A1 Meza, Luciana
A1 Morthy, Samira Saady
A1 Ovalle, Rudy
A1 Martínez, Stalin
A1 Pérez Orpinel, Oscar A
A1 Potito, Mauricio
A1 Orellana, Otto
A1 Baez, Jorge Marte
A1 Sandoval, Consuelo Orihuela
A1 Fernandez, Marcos Granillo
A1 Loomba, Rohit
A1 Flores, Saúl
A1 Hernández Hernández, José M
A1 Pignatelli, Ricardo
YR 2022
UL http://medrxiv.org/content/early/2022/01/11/2022.01.10.22269002.abstract
AB Objectives To describe the use and findings of cardiopulmonary imaging - chest X-ray (cX-ray), echocardiography (cEcho), chest CT (cCT), lung ultrasound (LUS)) and/or cardiac magnetic resonance imaging (cMRI) - in COVID-19-associated hospitalizations in Latin America (LATAM)Background The SARS-Cov-2 is one of the largest and most active threats to healthcare in living memory. There is an information gap on imaging services resources (ISR) used and their findings during the pandemic in LATAM.Methods This was a multicenter, prospective, observational study of COVID-19 inpatients conducted from March to December 2020 from 12 high-complexity centers in nine LATAM countries. Adults (> 18 yrs) with at least one imaging modality performed, followed from admission until discharge and/or in-hospital death, were included.Results We studied 1435 hospitalized patients (64% males) with a median age of 58 years classified into three regions: 262 from Mexico (Mx), 428 from Central America and Caribbean (CAC), and 745 from South America (SAm). More frequent comorbidities were overweight/obesity (61%), hypertension (45%), and diabetes (27%). During hospitalization, 58% were admitted to ICU. The in-hospital mortality was 28% (95%CI 25-30) highest in Mx (37%).The most frequent cardiopulmonary imaging performed were cCT (61%)-more frequent in Mx and SAm-, and cX-ray (46%) -significantly used in CAC-. The cEcho was carried out in 18%, similarly among regions, and LUS in 7%, more frequently in Mx. The cMRI was performed in only one patient in the cohort. Abnormal findings on the cX-ray were related to peripheral (63%) or basal infiltrates (52%), and in cCT with ground glass infiltrates (89%). Both were more commonly in Mx. In LUS, interstitial syndrome (56%) was the most related abnormal finding, predominantly in Mx and CAC.Conclusions The use and findings of cardiopulmonary imaging in LATAM varied between regions and may have been influenced by clinical needs, the personnel protection measures and/or hospitalization location.Condensed Abstract The SARS-Cov-2 is one of the largest and most active threats to healthcare in living memory. There is limited information on imaging services resources (ISR) used and their findings during the pandemic in LATAM.To our knowledge, RIMAC aimed the first international, multicenter study at registering the use and findings of cardiopulmonary imaging modalities performed for the diagnosis, prognosis, and treatment of patients hospitalized for infection with SARS-CoV-2 in Latin America. We studied their demographic parameters, comorbidities, in-hospital events, laboratory results, and treatments focusing on their impact in clinical complications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Hospital Israelita Albert Einstein, Sao Paulo, Brazil; CEDIMAT, Santo Domingo, Republica Dominicana; Hospital General de Medellin, Medellin, Colombia; Clinica Davila, Santiago de Chile, Chile; Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Ciudad de Mexico, Mexico; HNG Almenara Irigoyen, Lima, Peru; Hospital El Cruce, Provincia Buenos Aires, Argentina; Centro Medico Nacional 20 de Noviembre, Ciudad de Mexico, Mexico; Hospital general de Zona Numero 4, Monterrey, Mexico; Hospital Nossa Senhora das Gracas y Universidade Federal do Parana, Brazil; Complejo Hospitalario Dr Arnulfo Arias Madrid, Ciudad de Panama, Panama; and TECNISCAN Hospitalia, Ciudad de Guatemala, Guatemala gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsBMIBody Mass IndexCACCentral America and Caribbean regioncCTchest computed tomographycEchoechocardiogramcMRIcardiac magnetic resonance imagingCOPDChronic obstructive pulmonary diseasecX-raychest R-rayDBTdiabetesECGelectrocardiogramFaRVright ventricular fractional areaFWSRVright ventricular free wall strainGLSLVleft ventricular global longitudinal strainHBPhigh blood pressureICUintensive care unitIRBinstitutional Review BoardISRimaging services resourcesLUSlung ultrasoundLVEFleft ventricular ejection fractionMVmechanical ventilationMxMexican regionSAmSouth America region